SCHERING logo 228 (Fulvicin P G ultramicrocrystalline 125 mg)
Generic Name: griseofulvin
Pill imprint SCHERING logo 228 has been identified as Fulvicin P G ultramicrocrystalline 125 mg.
Fulvicin P/G is used in the treatment of tinea capitis; dermatophytosis; tinea barbae; tinea corporis; onychomycosis, fingernail (and more), and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy. Fulvicin P/G ultramicrocrystalline 125 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- ultramicrocrystalline 125 mg
- Prescription only
More about Fulvicin P/G (griseofulvin)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.